跳至主要内容
临床试验/IRCT20190714044201N1
IRCT20190714044201N1已完成2 期

Safety and efficacy of Amniotic Membrane in Asherman's syndrome management

Sarem Fertility and Infertility Research Center0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Asherman's patients with intrauterine adhesions and endometrial atrophy
  • endometrial thickness of less than 5 mm
  • normal functioning of the heart kidneys and lungs
  • wish to complete the study

排除标准

  • Unwilling to get pregnant
  • Genital tract inflammation
  • Cardiovascular diseases
  • Hormonal Problems Contraceptive Indication of Relative Hormone Therapy
  • Gastrointestinal diseases
  • prohibits estrogen use
  • liver or chronic hepatic failure
  • Immune system diseases such as lupus, ...
  • Past and present cancer
  • Positive serologic evidence of previous or current hepatitis B and C infection as well as HIV and HTLV

研究者

发起方
Sarem Fertility and Infertility Research Center

相似试验